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Summary We established a vindesine-resistant (x 11.6) human small-cell lung cancer cell line (H69/VDS) by
stepwise exposure of parent line H69 to vindesine. H69/VDS showed cross-resistance to taxol (x 10.1),
vincristine (x 6.9) and colchine (x 3.4) but not to doxorubicin, cisplatin or etoposide. There was no significant
difference in intracellular ['H]-vincristine and doxorubicin accumulation between H69 and H69/VDS cells. The
human mdrl mRNA was not detected in either of the cell lines. These results indicated that H69/VDS did not
express a typical multidrug resistant phenotype. Addition of 20 iM verapamil enhanced the growth inhibitory
effect ofvindesine on both H69/VDS (x 12.0) and H69 cells (x 3.8). The amount of total tubulin in H69/VDS
cells was lower than that in the H69 parental cells. No significant increase was observed in the amount of total
and polymerised tubulins of H69 cells. In H69/VDS cells, however, verapamil increased the amount of total
tubulin to the level of parental cells, but decreased the amount of polymerised tubulin. Modulation of tubulin
may play a role in the resistance to vindesine.
One of the main reasons for failure of chemotherapy is
believed to be the emergence of cellular drug resistance. It is
therefore very important to identify mechanisms of drug
resistance in order to improve the clinical efficacy of
chemotherapy. Vindesine is one of the effective drugs against
human small-cell lung cancer (Bunn et al., 1989). Resistance
to vinca alkaloids and taxol involves the multidrug resistant
phenotype caused by the mdrl gene product, P-glycoprotein.
However, mechanisms other than P-glycoprotein mediated
drug efflux may also be important in clinical resistance of
human lung cancer (Lai et al., 1989). We have tried to
establish a vindesine-resistant human small-cell lung cancer
cell line with a different mechanism to that of the typical
mdrl mediated multidrug resistance. We were successful in
establishing a vindesine-resistant cell line without elevated
expression of the mdrl gene or increased drug efflux. We
believe that this vindesine-resistant cell line is unique and
may be useful in elucidating the vindesine resistance
mechanism in human small-cell lung cancer.
Materials and methods
Chemicals
Vindesine and vincristine were purchased from Shionogi
Pharmaceutical Co. (Osaka, Japan). Taxol, cisplatin and
etoposide were obtained from Bristol-Myers Squibb (Tokyo,
Japan). Doxorubicin was purchased from Kyowa Hakko
Kogyo (Tokyo). RPMI 1640 medium and phosphate-buffered
saline (PBS) were purchased from Nissui (Tokyo). Anti-a-
tubulin antibody was purchased from Seikagaku Corporation
(Tokyo). [3H]vincristine sulphate ([3H]-VCR) was purchased
from Amersham Japan (Tokyo). Protein G Sepharose 4 Fast
Flow was purchased from Pharmacia LKB Biotechnology
AB (Uppsala, Sweden). Other chemicals were purchased
from Sigma Chemical Co. (St. Louis, MO) unless otherwise
stated.
Establishment ofa vindesine-resistant human lung cancer cell
line
A vindesine-resistant cell line was established by stepwise
exposure of H69 cells to increasing concentrations of the
drug. H69 human small-cell lung cancer cell line was estab-
lished at the National Cancer Institute (Bethesda, USA), and
stock cultures were obtained from Dr Y. Shimosato
(National Cancer Center Research Institute, Tokyo, Japan).
The cells were propagated in RPMI 1640 medium supple-
mented with 10% heat-inactivated foetal bovine serum,
penicillin (100 IU x ml- ') and streptomycin (100 gig x ml-')
(RPMI-FBS) at 37°C in a balanced air humidified incubator
with an atmosphere of 5% CO2. The resistant cell line was
developed by the continuous exposure to vindesine starting
with 0.1 nM and increased in a stepwise manner to 10 nM.
We isolated a H69 subline resistant to vindesine-induced
growth inhibition (H69/VDS) by twice using a limiting dilu-
tion method. Briefly, we placed 150 gil of medium containing
10 nM of vindesine into each well of a 96-well tissue culture
plate. We added 1501gI of cell suspension (1 x 103 cells
x ml-') containing 10 nM vindesine to the first set of wells.
We then transfered half of the cell suspension from these
wells to the next group of wells and diluted by 2-fold with
medium. We repeated the dilution procedure until a propor-
tion of wells contained only a single cell. We then incubated
the plates for a period of one month. In some wells a colony
was produced from a single cell. The established vindesine-
resistant cell line was obtained from such a colony and grew
continuously in medium containing 10 nM vindesine. The
cells were used in experiments after being cultivated in drug-
free medium for 7 days.
Doxorubicin resistant K562/ADM cells (Tsuruo et al.,
1986) and etoposide resistant H69/VP cells (Minato et al.,
1990) were used as positive controls for typical mdrl express-
ing cells.
Growth-inhibitory assay
To determine the growth-inhibitory effects of the drugs, we
used the tetrazolium dye assay of Mosmann (1983). Briefly,
100 gil aliquots of an exponentially growing cell suspension
(1 x I05 cells x ml-1) were seeded in 96-well microtiter plates
and incubated for 6 h. One hundred gIl aliquots of the drugs
at various concentrations were added. After exposure to the
drugs for 96 h, 20 glA of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide (MTT) solution (5 mg x ml-' in
PBS) was added to each well and the plates were incubated
at 37°C for a further 4 h. After centrifugation of the plates at
800 g for 5 min, the medium was aspirated from each well as
completely as possible. Two hundred gil of dimethyl sulfoxide
(DMSO) was added to each well to dissolve the formazan.
The optical density was measured at 562 and 630 nm using
Delta-soft ELISA analysis for a Macintosh computer inter-
faced to a Bio-Tek Microplate Reader (EL-340, Bio Metal-
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lics, Princeton, NJ.). Wells containing only RPMI-FBS and
MTT were used as control. Each experiment was performed
using 6 replicate wells for each drug concentration and three
independent experiments were carried out. The IC50 was
defined as the drug concentration required for 50% reduction
of the optical density in each test and was calculated as
(mean absorbance in six wells containing drug - absorbance
in six control wells)/(mean absorbance in six drug-free wells -
absorbance in six control wells) x 100. The relative resistance
was defined as IC50 of the resistant subline/IC50 of the paren-
tal cell line.
Accumulation assay
For the determination of [3H]-VCR accumulation, exponen-
tially growing cells (2 x 106 cells x ml-') were incubated with
1, 5 and 10 nM[3H]-VCR at 37°C for 3 h. Cells were washed
twice with ice-cold PBS and cell pellets after centrifugation
were dissolved in 1 ml 90% formic acid. Four ml of Clear-
SOIRM 1 solution was added (Nacalai Tesque, Kyoto, Japan)
to the tubes and radioactivity was measured with a liquid
scintillation counter (LS6000TA, Beckman, Irvine, CA.).
Etoposide resistant H69/VP cells were used as positive con-
trols for typical mdrl expressing cells (Minato et al., 1990).
For the determination of the time course of [3H]-VCR efflux,
exponentially growing cells (2 x 106 cells x ml-') were
incubated with 10 nM [3H]-VCR at 37°C for 3 h. Cells were
washed twice with ice-cold PBS and incubated in complete
medium (RPMI-FBS) without vincristine for 30 to 120 min.
Cells were washed twice with ice-cold PBS and cell pellets
after centrifugation were dissolved and radioactivity was
measured with a liquid scintillation counter. The protein
concentration of control samples was measured by a BCA
protein assay kit (Pierce, Rockford, IL.). For the determina-
tion of doxorubicin accumulation exponentially growing cells
(1 x 106 cells x ml-') were incubated with 10 and 1I00 1M
doxorubicin with or without 20ZlM of verapamil containing
0.025% DNase at 37°C for 3 h (Versantvoort et al., 1992).
Cells were washed twice with ice-cold PBS and cell pellets
after centrifugation were dissolved with 2001lI of dimethyl
sulfoxide, and then cellular proteins were precipitated by the
addition of 1.8 ml of absolute methanol. The fluorescence
intensity of the extracts was determined using a fluorescence
spectrophotometer (FP-777; Japan Spectroscopic Co., Ltd.,
Tokyo, Japan) at excitation and emission wave-lengths of
470 and 550nm, respectively (Horichi et al., 1990).
RNA extraction and Northern blot analysis
RNA was extracted from the parent and vindesine-resistant
cell lines by the acid guanidinium thiocyanate-phenol-
chloroform extraction method (Chomczynski & Sacchi,
1987). Twenty ltg of total RNA was electrophoresed on a 1%
agarose-6% formaldehyde gel at 25 V for 12 h. The RNA
was transferred to a positively charged nylon membrane
(Hybond-N+, Amersham Japan), which was then hybridised
overnight with a 32P-labelled DNA probe at 42°C. The probe
was labelled with [x-32PJ-dCTP by means of a multiprime
labelling system kit (Amersham Japan). After hybridisation,
the membrane was washed three times with 2 x SSC
(1 x SSC consists of 0.15 M NaCl and 0.015 M sodium cit-
rate) and 0.1% SDS for Omin. After 3 x washes with
0.1 x SSC and 0.1% SDS for 15 min at 65°C, followed by
several washes with 0.1 x SSC, the membrane was
autoradiographed on X-ray film (Amersham Hyperfilm-MP)
at - 70°C for 3 days. The probe used, pmdrl (coding for
human mdrl) (Roninson et al., 1986), was kindly provided by
I.B. Roninson (University of Ilinois).
Preparation of whole cell lysatesfor determination ofthe total
tubulin level
Total tubulin was isolated by a modification of the method
reported by Thrower et al. (1991) and Minotti et al. (1991).
Exponentially growing cells were washed twice with PBS,
collected and adjusted to 5 x 105 cells x ml-'. One ml of
each cell suspension was centrifuged at 200g for 5 min, and
resuspended in 0.3 ml of depolymerisation buffer (0.1 M
MES, 1 mM MgSO4, 10 mM CaC12, 5 mM GTP, pH 6.9). Cells
were lysed by sonication on ice with a Branson Sonifier 450
(Branson ultrasonics, Danbury, CT) at 15 W output for two
intervals of 15 s each. Lysate fractions were incubated in
depolymerisation buffer for 1 h on ice to depolymerise the
microtubules. Following depolymerisation, samples were
centrifuged at 50,000g for 15min at 4°C using a TL-100
centrifuge (Beckman) with a fixed-angle TL-45 rotor. The
supernatant was transferred to a new centrifuged tube. After
addition of 30 jtl protein G sephrose 4 Fast Flow
(Pharmacia-LKB) and overnight mixing at 4°C, the tube was
centrifuged at 250g for 5 min. The supernatant was transfer-
red to a new centrifuge tube, anti-x-tubulin antibody was
added and the tube mixed for 1 h at 4°C. To each sample
was then added 30yl protein G sephrose followed by mixing
for 1 h at 4°C and washing with 3 times depolymerisation
buffer. To the pellet was added 50 tl SDS sample buffer
(0.25M Tris-HCI, 2% sodium dodecyl sulfate (SDS), 30%
glycerol, 10% 2-mercaptoethanol, 0.01% bromophenol blue
pH 6.8), and the mixture was then denatured at 90°C for
1 min and subjected to electrophoresis in a 10% SDS-
polyacrylamide gel (PAG PLATE 10, Daiichi Pure
Chemicals). The separated protein was stained using a silver
stain (Sil-best Stain, Nacalai Tesque).
Preparation ofwhole cell lysatesfor determination ofthe
polymerised tubulin content
Polymerised tubulin was isolated by a modification of the
Thrower and Minotti method. Briefly, exponentially growing
cells were washed twice with warm PBS, collected and
adjusted to 5 x 105 cells x ml-. One ml of each cell suspen-
sion was centrifuged at 200g for 5 min. The pellet was
resuspended in 1 ml of stabilisation buffer (20 mM Tris-HCl,
pH 6.8, 0.14 M NaCl, 0.5% Nonidet P-40, 1 mM MgCl2,
2 mM EGTA, 4ltg ml1' taxol) and incubated at 37°C for
30 min. Each sample was centrifuged at 50,000g for 15 min
at 37°C. The supernatant was aspirated and the pellet was
resuspended with 0.3 ml of depolymerisation buffer. Follow-
ing this step the lysate was treated in a similar manner to the
total tubulin isolates, with 1 h incubation on ice, centrifuga-
tion, immunoprecipitation, and electrophoresis.
Western blot analysisfor total andpolymerised tubulin
Total and polymerised tubulin contents were analysed on a
10% SDS-polyacrylamide gel. Following electrophoresis, the
protein on the gel was electrophoretically transferred to
nitrocellulose membranes (Towbin et al., 1979). The mem-
brane was incubated with blocking buffer (4% skimmed milk
in PBS for 1 h and was then allowed to react with anti-a-
tubulin antibody for 12 h at 4°C. After incubation, the mem-
brane was washed four times with PBS containing 0.1%
tween-20 and then incubated with biotinylated anti-mouse
IgG antibody at room temperature for 1 h. The bands were
detected by the ECL Western blotting detection method
(Amersham), and analysed with a Ultroscan XL enhanced
laser densitometer (Pharmacia LKB).
Results
General characteristics
Data in Table I list the general characteristics of the parental
H69 and the vindesine-resistant H69/VDS cell line. Cell
diameter was measured using a Coulter chanelyser 256 (Nik-
kaki, Tokyo). The diameter of H69/VDS cells was slightly
smaller than that of H69 cells, but the difference did not
reach statistical significance (unpaired Student t-test,
P = 0.09). The cell number doubling time of H69/VDS
(62.3 h) was significantly longer than that of H69 (51.3 h)
(P<0.05). The protein contents of H69/VDS (292jig 1 x10-6
cells) and H69 (270 Lgl 1 x10-6 cells) were similar.76 S. OHTA et al.
Table I Characteristics of H69 and H69/VDS
H69 H69/VDS
Diameter (pM)a 8.10o0.22b 7.44±0.74c
Doubling time (h) 51.3 5.8d 62.3 ± 3.5e
Protein content 270 292
(jAg x 10-6 cells)
aDiameters were measured using Coulter channeliser 256. "Each
value is the mean ± s.d. of five independent experiments. Each value
is the mean ± s.d. independent experiments. There was no significant
difference between the value of cell size for H69 and H69/VDS by
unpaired Student t-test (b VS C, p = 0.09). Significance in the
difference of doubling time between H69 and H69/VDS by unpaired
Student t-test (d VS e, p = 0.048).
Growth-inhibitory effects ofanticancer drugs in H69/VDS cells
The growth-inhibitory effects of various drugs in H69 and
H69/VDS cells were measured by the MTT assay and the
IC50's are shown in Table II. The relative resistance of H69/
VDS was highest against vindesine (x 11.6) and cross-
resistance to vincristine (x 6.9), colchicine (x 3.4) and taxol
(x 10.1) was evident (P<0.01, unpaired Student t-test). H69/
VDS did not show high cross-resistance to other drugs such
as doxorubicin (x 1.53), etoposide (x 0.87) or cisplatin
(x 0.61). There were no significant differences in the ICso's
value for these drugs between H69 and H69/VDS by
unpaired Student t-test. The resistance pattern of H69/VDS
cells was therefore different from that of the typical multi-
drug resistance phenotype. It was interesting to note that
H69/VDS cells had cross-resistance not only to vincristine,
colchicine but also to taxol, which has a different mechanism
of action on tubulin compared with vinca alkaloids (Schiff et
al., 1979; Schiff & Horwitz, 1980).
Accumulation study
To determine whether decreased drug accumulation was a
cause of resistance, we examined the intracellular accumula-
tion of [3H]-VCR in H69 and H69/VDS cells. Table III
shows the intracellular concentrations of [3H]-VCR after the
addition of 1, 5, and 10 nM [3H]-VCR to the culture medium
Table H Sensitivities to various agents in the MTT assay
IC50a (pM) Relative
Drug H69 H69/VDS resistancec
VDS 0.00167 ± 0.00009b 0.0193 ± 0.0009 11.6d
Taxol 0.0062 ± 0.0023 0.063 ± 0.020 10.1d
VCR 0.0020 0.0001 0.0137 ± 0.0012 6.85d
Colchicine 0.00153 ± 0.00025 0.00514 ± 0.00015 3.36d
DOX 0.150 ± 0.020 0.230 ± 0.060 1.53e
Etoposide 5.627 ± 0.404 4.63 ± 0.67 0.87e
CDDP 2.74± 1.31 1.66 ± 0.81 0.61e
aDrug concentration that inhibits cell growth by 50%. "Each value
is the mean ± s.d. of three or five independent experiments. cRelative
resistance value equals the IC50 value of resistant cell line divided by
the IC50 value of parental cell line. dp <0.01 (unpaired Student's
t-test). 'Not significant (unpaired Student's t-test).
Table III Accumulation of [3H]-VCR for 3 h in H69 and H69/VDS
cells
Intracellular[3H1-VCR (pmol x lo-6cells)
VCR (nM) VER (LM) H69 H69/VDS
1 0 22.47+1142a,b 26.35± 14.9c
5 0 80.38±28.37d 103.53± 15.52e
10 0 175.45±42.671 160.72±40.659
10 20 250.85±39.8h 317.43±83.27i
aEach value is the mean±s.d. of three independent experiments.
There was no significant difference between the value for H69 and
H69/VDS at each concentrations by unpaired Student's t-test. b VSc,
P=0.817.dvse,P=0.113.fvsg, P=0.55. vs, P = 0.108. Significance
in the difference oftheconcentration of[3H]VCR in H69 and H69/VDS
between VCR only and VCR + VER by unpaired Student t-test. f vsh,
P=0.01. 9 vs', P=0.002.
for 3 h. The amount of intracellular radioactivity of [H]-
VCR increased in both H69 and H69/VDS cells with the
increased concentration of [3H]-VCR in the medium. There
was no statistical difference in the intracellular [H]-VCR
content of H69 and H69/VDS cells at any of the concentra-
tions tested. Figure 1 shows that the time course of accumu-
lation of [3H]-VCR in H69 and H69/VDS cells was not
significantly different. Similarly, there was no significant
difference in the time course of efflux in H69 and H69/VDS
cells (Figure 2). Etoposide-resistant H69/VP cells were used
as positive controls as for typical mdrl expressing cells
(Minato et al., 1990). In H69/VP cells the intracellular [3H]-
VCR retention was lower than in other cells (Figure 2). Table
IV shows the accumulation of doxorubicin after 3 h exposure
in H69, H69/VDS and H69/VP cells. There was no signifi-
cant difference between the values for H69 and H69/VDS at
each concentration. There was however a statistical difference
in the concentration of doxorubicin between H69 and H69/
VP cells. An enhancing effect of verapamil on the accumula-
tion of doxorubicin in H69/VP was obtained. In H69 and
H69/VDS however, no significant effect of verapamil on the
accumulation of doxorubicin was observed. This result sug-
gests that alteration of intracellular accumulation of [3H]-
VCR and doxorubicin was not responsible for the sensi-
tivities to vincristine and doxorubicin in H69/VDS cells,
respectively. H69/VDS did not show a typical multidrug
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Figure I Time course of cellular uptake and retention of [3H]-
VCR. H69 (open circle) or H69/VDS (closed square) cells were
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Figure 2 Time course ofefflux of[3H]-VCR in H69 (open circle),
H69/VDS (open square), H69/VDS with 20gM of verapamil
(closed square) and H69/VP (triangle). After 3 h exposure with
1OtOM of [3H]-VCR with or without verapamil, cells were washed
with drug free medium and [3H]-VCR retained was examined at
30, 60 and 120 min.VINDESINE RESISTANT CELL LINE 77
Table IV Accumulation of DOX for 3 h in H69, H69/VDS and H69/VP cells
Intracellular DOX (pmol x lo-6 cells)
DOX ("sM) VER (gM) H69 H69/VDS H69/VP
10 0 1.22±0.18ab 1.50+0.28c 0.87±0.15d
100 0 3.36±0.35c 3.21±0.61i 1.74±0.109
100 20 3.31 ±0.29h 3.26±0.36' 2.35±0.22i
aEach value is the mean±s.d. of three independent experiments. There was no
significant difference between the value for H69 and H69/VDS at each concentration by
unpaired Student's t-test. Significance in the difference of the concentration of DOX
between H69and H69/VP byunpaired Student t-test. b VSd, p<0.01. VS , p<0.01.h VSj,
P<0.01 g vs i, P<0.01.
Northern blot analysis
To confirm that H69/VDS did not have P-glycoprotein
mediated multidrug resistant phenotype, we examined the
mdrl mRNA expression in H69/VDS by Northern blot
analysis. Doxorubicin resistant K562/ADM cells (Tsuruo et
al., 1986) and etoposide resistant H69/VP cells were used as
positive controls for typical mdrl expressing cells. The
human mdrl mRNA was not detected in H69/VDS cell line
thus suggesting that the resistance of H69/VDS was not
mediated by the mdrl gene (Figure 3).
Reversal ofvindesine resistance by verapamil
We examined the effect of Ca2"-channel blocker, verapamil
on vindesine cytotoxicity in H69 and H69/VDS cells. We also
evaluated the toxicity of verapamil alone on H69 and H69/
VDS cells using a dose range of 0.1JM to 1,000tLM. We
found that 20iLM of verapamil was not toxic to either cell
line (Figure 4). The viability of both cell lines was more than
90% after 96 h exposure to 20,LM of verapamil in three





Figure 3 Northern blot analysis ofmdrl in H69 and H69/VDS.
The doxorubicin resistant cell line (K562/ADM) and etoposide-
resistant cell line (H69/VP) were used as the positive control. a,
The human mdrl mRNA (4.3 kb). b, Ethidium bromide-stained
RNA.
alone were 1.9 and 24.0 nM for H69 and H69/VDS, respec-
tively (Figure 5). In the presence of 20lAM verapamil, the
IC50's for vindesine in H69 and H69/VDS decreased to 0.5
and 2.0 nM415, respectively. Twenty f4M of verapamil
enhanced by 12-fold the growth-inhibitory effect of vindesine
in H69/VDS cells. In H69 parental cells the corresponding
sensitisation was only 3.8-fold, and therefore selective sen-
sitisation by verapamil of the resistant cells was seen.
In order to determine whether verapamil influenced the
intracellular accumulation of vincristine, H69 and H69/VDS
cells were incubated with 10 nM of [3H]-VCR in the presence
or absence of 20ylM of verapamil for 3 h. Data in Table III
show that, in the presence of verapamil, intracellular [3H]-
VCR content was increased from 175.4 to 250.9 pmol per 106
cells, and from 160.7 to 317.4 pmol per 106 cells in H69 and
H69/VDS respectively. Verapamil increased the intracellular
accumulation of [3H]-VCR in both cell lines. However, in the
presence of verapamil, the intracellular accumulation of [3H]-
VCR in H69/VDS cells was not significantly different from
that in H69 cells. Verapamil did not increase the intracellular
accumulation ofdoxorubicin in either H69 or H69/VDS cells,
although it did so in H69/VP cells (Table IV). These results
suggest that the reversal of vindesine-resistance in H69/VDS
by verapamil could not be explained by an increase in the
intracellular accumulation of vincristine. Considering that
H69/VDS cells neither expressed mdrl mRNA nor had
reduced intracellular retention of vincristine reversal of
vindesine-resistance by verapamil must be based on a
mechanism other than decreased drug efflux induced by
verapamil.
Tubulin content
We examined other mechanisms which might possibly be
responsible for resistance to tubulin-acting agents in H69/
VDS. As H69/VDS showed cross-resistance to vindesine,
vincristine, colchicine, and taxol, drugs which are known to
intereact with microtubules, we considered that changes in
tubulin might be related to the resistance of H69/VDS cells.


















Figure 4 Cytotoxicity of verapamil in H69 and H69/VDS cells.
H69 (open circle) and H69/VDS (closed square) cells were
exposed with various concentration of verapamil for 96 h, the
growth-inhibitory effect of verapamil was measured by the MTT
assay from three independent experiments.
_4-_
0 1 10 100 1000
VDS (nmol ml-1)
Figure 5 The enhancement on the cytotoxicity of vindesine in
presence (closed symbol) or absence (open symbol) of 20 1M of
verapamil was evaluated in H69 (square) and H69/VDS (cir-
cle).
I k/
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polymerised tubulins in H69/VDS and H69 cells, we
measured by immunoprecipitation the total and polymerised
tubulin contents after incubating cells in the presence or
absence of 20JM verapamil (Figure 6). The polymerised
tubulin ratio is defined as the ratio of polymerised tubulin
content to total tubulin content. The polymerised tubulin
ratio in H69/VDS in the absence of verapamil was higher
than that of H69. In H69, 201 M of verapamil slightly in-
creased the amount of total and polymerised tubulins, but
the polymerised tubulin ratio remained unchanged. On the
other hand, in H69/VDS, 20JM of verapamil increased the
amount of the total tubulin, but decreased the amount of
polymerised tubulin resulting in a decrease in the polymerised
tubulin ratio. This effect of verapamil on the total and
polymerised tubulins in H69/VDS is consistent with the
reversal of resistance by verapamil in H69/VDS. The de-
creased polymerised tubulin ratio caused by the addition of
verapamil might explain the reversal ofvindesine and vincris-
tine resistance in H69/VDS.
Dose and time dependent effects ofverapamil on the amount of
the total tubulin
We observed two bands of 68 and 54 kDa by immunopre-
cipitation assay. The 68 kDa band was not detected by
Western blot analysis and so this band was considered to be
the tubulin-related protein. The 54 kDa band was identified
as a-tubulin by reblotting. Total x-tubulin content of H69/
VDS cells was significantly lower than that of the H69
parental cells (Figure 6). The time and dose dependent effects
of verapamil on tubulin content were evaluated. The total
tubulin content was increased in H69/VDS, as the concentra-
tion verapamil was increased from 5 to 10 20JAM (Figure 7a).
The time-dependent change in the total tubulin content was
evaluated in cells co-incubated with 20JAM of verapamil
(Figure 7b). Increase in tubulin content caused by verapamil
H69 H69NDS
Verapamil - - + + - - + +
(20LM) T P T P T P T P
exposure was observed after 2 days. These results suggest
that verapamil increased the tubulin content of H69/VDS
cells in a both time- and dose-dependent manners.
Dose dependent effects ofverapamil on polymerised tubulin
ratio examinedby Western blotting
The dose dependent effects of verapamil on polymerised
tubulin ratio were evaluated by Western blotting (Figure 8).
The total tubulin content after exposure to 0.1 to 20JLM of
verapamil was higher than that without verapamil in H69/
VDS. Whereas the polymerised tubulin content was
decreased. The polymerised tubulin ratio was therefore
decreased by the co-incubation with verapamil.
Discussion
Resistance to vinca alkaloids and taxol has been reported to
involve the typical P-glycoprotein mediated multidrug resis-
tance and increased drug efflux (Roy & Horwitz, 1985; Beck,
1987). In the vindesine resistant small-cell lung cancer cell
line, H69/VDS which we established, cross-resistance to
tubulin interacting agents such as vindesine, vincristine, col-
chicine and taxol was apparent (Table II). However, H69/
VDS did not show cross-resistance to doxorubicin, etoposide
and cisplatin (Table II). The resistant pattern of H69/VDS
seemed to be different from that of the typical multidrug
resistance phenotype. The expression of mdrl mRNA was
negative by Northern blot analysis in H69/VDS. The drug
accumulation and efflux were equal in H69 and H69/VDS.
Although verapamil could reverse the drug resistance in H69/
VDS, the changes in accumulation of the drugs brought
about by verapamil were the same in H69 and H69/VDS
(Table III). The concentration (20JiM) of verapamil used in
these experiments was not toxic to either of the cell lines. The
viabilities of both cell lines were more than 90% after 96 h
exposure with 20JAM of verapamil. Based on these data, it
was strongly suggested that mdrl gene expression is not
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Figure 6 Influence of verapamil on the total and polymerised
tubulin. H69 and H69/VDS cells were incubated with presence or
absence of 20JM of verapamil for 4 days, and total and
polymerised tubulin contents of both cell lines were measured.
Lane I indicated total tubulin content without verapamil in H69.
Lane 2 indicated polymerised tubulin content without verapamil
in H69. Lane 3 indicated total tubulin content with verapamil in
H69. Lane 4 indicated polymerised tubulin content with
verapamil in H69. Lane 5 indicated total tubulin content without
verapamil in H69/VDS. Lane 6 indicated polymerised tubulin
content without verapamil in H69/VDS. Lane 7 indicated total
tubulin content with verapamil in H69/VDS. Lane 8 indicated














1 2 3 4 5 6 7 8 9 10
Verapamil 0 0.1 0.5 1 20 0 0.1 0.5 1 20
(AM) I l l
Total Polymerised
Figure 8 Total and polymerised a-tubulin contents in H69/VDS
by Western blotting with anti-a-tubulin antibody. H69/VDS cells
were incubated by 0, 0.1, 0.5, 1 and 20JAM of verapamil for 4
days. AU stands for arbitrary units.
a b
Duration H69NDS H69




Figure 7 Total a-tubulin contents in H69 and H69/VDS by immunoprecipitation by anti-a-tubulin antibody. The band of 68 kDa
was the tubulin related protein and the band of 54 kDa (arrow) indicated a-tubulin content. a, H69/VDS cells incubated with 0, 5,
10, and 20JAM of verapamil for 4 days. b, H69/VDS cells incubated with 20JAM of verapamil for 0, 2, and 4 days.VINDESINE RESISTANT CELL LINE 79
involved for the resistance of H69/VDS. The site of action of
vinca alkaloids is generally considered to be on the micro-
tubules. We therefore considered that some changes in the
tubulin might be related to the resistance of H69/VDS. By
immunoprecipitation with anti-o-tubulin antibody for the
comparison of the tubulin content of H69 and H69/VDS
cells two bands of 68 and 54 kDa were observed. The 54 kDa
band was identified as a-tubulin. On the other hand the
68 kDa band was not detected by Western blotting. At first
we were interested in 68 kDa immunoprecipitated protein.
There is a possibility that the 68 kDa immunoprecipitated
protein is the 68 kDa microtubule associated protein (Lim et
al., 1984) or a heat-shock protein 70 (Lee et al., 1992).
However, the change in the amount of the 68 kDa immuno-
precipitated protein was not reproducible in several
experiments. Because of these findings, we did not consider
that the 68 kDa protein was responsible for the resistance to
vindesine in H69/VDS cells.
Verapamil increased the total cellular tubulin content
(Figure 8). We investigated the synthesis of the total a-
tubulin content using a [35S]-methionine label to determine
whether the effect of verapamil in increasing in the total
tubulin content was due to an increase in synthesis. We did
not, however, observe any increase in the synthesis of the
total tubulin by the verapamil in H69/VDS (data not shown).
We are now investigating the possibility that verapamil might
influence the tubulin turnover.
As shown in the present study, the total and polymerised
tubulin contents of H69/VDS were lower than those of
parental H69 cells. The polymerised tubulin ratio in H69/
VDS was higher than that of H69 and was decreased by the
addition of verapamil in a dose-dependent manner (Figure
8). This result was consistent with the reversal of vindesine
resistance in H69/VDS by verapamil. Therefore we believe
that the increase in total tubulin and/or the decrease in the
polymerised tubulin ratio plays some role in the mechanism
of H69/VDS resistance. It has previously been reported that
a decrease in the total cellular tubulin pool occurs parallel
with an increase in microtubule depolymerisation (Jordan,
1991).
Taxol promotes the polymerisation of microtubules and
stabilises tubulin polymers by preventing their depolymerisa-
tion. It seems that the manner of action of taxol on tubulin
polymerisation is the reverse of that of vinca alkaloids. We
therefore expected H69/VDS cells to show a hypersensitivity
to taxol. However, H69/VDS cells showed cross-resistance to
taxol. It has been reported that taxol does not competitively
inhibit the binding ofcolchicine to tubulin (Schiff & Horwitz,
1981). This suggests that the binding site of taxol may be
different from that of colchicine. The cytotoxic action and
cytotoxic profile of taxol may not therefore be completely
adverse to those of vinca alkaloids. We thought it to be not
unreasonable therefore that H69/VDS did not show hyper-
sensitivity to taxol. However, it remains unclear why H69/
VDS did, in fact show cross-resistance to taxol. Further
investigations are necessary to clarify this question.
Verapamil is known for its capacity to circumvent the
typical multidrug resistance phenotype by reducing the in-
creased drug efflux in the resistant cells (Yusa & Tsuruo,
1989). On the other hand, verapamil has also been reported
to potentiate drug effects in the absence of P-glycoprotein
(Nygren & Larsson, 1990). The effect of verapamil on tubulin,
presented here, might indicate a new mode of action in
circumvention of vinca alkaloid resistance other than by
interaction with P-glycoprotein.
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